National Health Investors (NYSE:NHI) Shares Purchased Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of National Health Investors, Inc. (NYSE:NHI). In a filing disclosed on September 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in National Health Investors stock on July 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Mesabi Trust (NYSE:MSB) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of Praxis Precision Medicines (NASDAQ:PRAX) on 7/30/2026.
• Purchased $15,001 – $50,000 in shares of Alkermes (NASDAQ:ALKS) on 7/30/2026.
• Sold $15,001 – $50,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/30/2026.
• Sold $100,001 – $250,000 in shares of Alibaba Group (NYSE:BABA) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Adobe (NASDAQ:ADBE) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of SailPoint (NASDAQ:SAIL) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of Glacier Bancorp (NYSE:GBCI) on 7/21/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 7/21/2026.

National Health Investors Stock Performance

Shares of National Health Investors stock traded up $0.47 during trading on Tuesday, reaching $71.35. The company’s stock had a trading volume of 338,457 shares, compared to its average volume of 423,423. The company has a 50-day moving average price of $75.25 and a two-hundred day moving average price of $77.98. The firm has a market cap of $3.50 billion, a PE ratio of 20.62, a P/E/G ratio of 3.78 and a beta of 0.52. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The firm had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, analysts forecast that National Health Investors, Inc. will post 4.76 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is 108.67%.

Hedge Funds Weigh In On National Health Investors

Large investors have recently bought and sold shares of the company. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors in the fourth quarter valued at about $27,000. EverSource Wealth Advisors LLC lifted its position in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the period. Garton & Associates Financial Advisors LLC acquired a new stake in National Health Investors in the fourth quarter valued at about $33,000. Allworth Financial LP purchased a new stake in National Health Investors in the 2nd quarter valued at approximately $42,000. Finally, Advisory Services Network LLC purchased a new stake in National Health Investors in the 3rd quarter valued at approximately $65,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on NHI shares. Wells Fargo & Company decreased their target price on shares of National Health Investors from $79.00 to $78.00 and set an “equal weight” rating for the company in a research note on Tuesday, September 1st. Zacks Research cut National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Deutsche Bank Aktiengesellschaft reduced their price objective on National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research note on Thursday, June 25th. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Finally, BMO Capital Markets lowered their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research note on Monday, June 15th. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and an average price target of $83.57.

Insider Transactions at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction on Monday, June 15th. The shares were bought at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.70% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.